Dr Michael Slancar commenced his specialist training in medical oncology in Europe, under the auspices of European School of Oncology. He completed his training in Sydney, Australia. He held previous appointments at the Oncology Department of The Royal North Shore Hospital in Sydney until he moved to Queensland in 1998 and established Gold Coast Oncology, a co-ordinated cancer care practice in Southport. He also founded Gold Coast Oncology Research Pty Ltd, a private organisation specialising in international clinical trials. In 2008, he transitioned his established practice and research centre to HOCA and contributed to the establishment of HOCA Gold Coast at Southport – now known as Icon Cancer Centre Southport – the first truly comprehensive cancer centre in the region.
Dr Slancar has expertise in general oncology of solid tumours, with major interest in breast and gynaecological cancers, colorectal cancer, lung cancer, prostate cancer and lymphomas. His practice offers comprehensive management of any malignancy at any stage of the disease. This support spans the initial diagnosis to the palliative care stage. Dr Slancar has a keen interest in clinical trials and is an internationally recognised principal investigator. He continues to participate on a number of international studies in the treatment of solid tumors. At any time, he has access to a number of clinical studies available for treatment of major malignancies.
He also specialises in personalised medicine, co-operating with a number of international groups working on the best-individualised care for cancer patients, based on precise tumour profiling.